Latest Breaking News On - Holliday communications inc - Page 1 : vimarsana.com

Melt Pharmaceuticals Provides Corporate Update

Melt Pharmaceuticals Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDeb hollidayLarry dillahaCatalent incHolliday communications incPharmaceuticals incDrug administrationHarrow incSafety studyMelt pharmaceuticalsNorth america

Harrow Acquires U S and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0 1

VEVYE® is the First and Only Cyclosporine-Based Product Indicated for the Treatment of Both Signs and Symptoms of Dry Eye Disease with Efficacy Demonstrated After Four WeeksVEVYE® is the Only Water-Free Ophthalmic Product with Convenient Twice-Daily (BID) DosingNASHVILLE, Tenn. & HEIDELBERG, Germany (BUSINESS WIRE).

United statesBaden wübergUnited kingdomDeb hollidayPaul karpeckiLauram perimanMarkl baumNovaliq gmbJamie webbChristian roeskyUniversity of pikevillePeriman eye instituteSurface ophthalmics incPharmaceuticals incEye servicesGmbh co

Harrow Acquires Santen s Branded Ophthalmic Portfolio

Transaction Includes U.S. and Canadian Commercial Rights to FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, ZERVIATE®, and Non-Prescription Brands FRESHKOTE® and Cationorm® PLUSNASHVILLE, Tenn. (BUSINESS WIRE) $HROW Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the signing of a.

United statesDeb hollidayRichardl lindstromMarkl baumJamie webbPharmaceuticals incSurface ophthalmics incHolliday communications incExchange commissionHarrow health incSanten pharmaceutical co ltdCanadian commercial rightsNon prescription brandsImportant safety informationFull prescribing informationChief executive officer

Harrow Health (HROW) Acquires Santen s Branded Ophthalmic Portfolio

Harrow Health (HROW) Acquires Santen s Branded Ophthalmic Portfolio
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMarkl baumDeb hollidayRichardl lindstromJamie webbSurface ophthalmics incExchange commissionHarrow health incHolliday communications incPharmaceuticals incSanten pharmaceutical co ltdImportant safety informationFull prescribing informationChief executive officerOaktree capital managementSurface ophthalmics

Harrow Health, Inc : Harrow Acquires U S and Canadian Commercial Rights to VEVYE (Cyclosporine Ophthalmic Solution) 0 1% from Novaliq

Harrow Health, Inc : Harrow Acquires U S and Canadian Commercial Rights to VEVYE (Cyclosporine Ophthalmic Solution) 0 1% from Novaliq
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesBaden wübergUnited kingdomChristian roeskyPaul karpeckiNovaliq gmbMarkl baumLauram perimanSimone angstmann mehrDeb hollidayJamie webbHarrow health incUniversity of pikevilleClinical researchSurface ophthalmics incPeriman eye institute